Calling for Unity, Solidarity, Continuity, and Access-Oriented Action in Times of War Birgit R. BuergiThalia ArawiAleksander Wiśniewski Editorial Open access 02 June 2022 Pages: 147 - 151
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets Rani Lill AnjumRebecca E ChandlerElena Rocca Current Opinion Open access 29 April 2022 Pages: 153 - 161
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice Ajeet GajraAbigail ZalenskiAnkit Kansagra Current Opinion Open access 07 June 2022 Pages: 163 - 171
Chaos to Clarity: Pragmatic Approaches to Overcome Challenges for Successful Implementation of Additional Risk Minimisation Measures in the European Union and the UK by a Marketing Authorisation Holder Kalindi HapaniNipa ParikhHarshil Patel Original Research Article 13 April 2022 Pages: 173 - 188
The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases Celine AertsEliana BarrenhoElisa Sicuri Original Research Article Open access 19 May 2022 Pages: 189 - 197
Major Pharmaceutical Conferences and Courses: August to September 2022 Update 03 May 2022 Pages: 199 - 200